Home / Recalls / Actavis / D-599-2013

D-599-2013 Class III Terminated

Recalled by Actavis — Salt Lake City, UT

Recall Details

Product Type
Drugs
Report Date
June 19, 2013
Initiation Date
June 3, 2013
Termination Date
April 9, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
98,952 boxes

Product Description

Fentanyl Transdermal System, 50 mcg/h, 1 system per pouch (NDC 0591-3212-54), packaged in 5-count systems per box (NDC 0591-3212-72), Rx only, Manufactured by Watson Laboratories, Inc, Corona, CA, 92880 USA; Distributed by: Watson Pharma, Inc.

Reason for Recall

Failed Impurities/Degradation Specifications

Distribution Pattern

Nationwide

Code Information

Lot #: Patch 453658; Carton 453658A, Exp 09/13

Other recalls by Actavis

  • D-0514-2017 Class III — Levofloxacin Ophthalmic Solution, 0.5%, Sterile, packaged in 5mL bottles, Rx On (February 7, 2017)
  • D-0476-2017 Class II — Glipizide extended-release tablets, 2.5mg, 30-count bottle, Rx Only, Manufactu (January 30, 2017)
  • D-0439-2017 Class III — Albuterol Sulfate Inhalation Solution, USP, 0.021% (0.63 mg / 3 mL), 3mL Vials, (January 12, 2017)
  • D-1472-2016 Class III — Hydrocortisone and acetic acid otic solution, Rx only, 10 mL bottle, Distributed (August 2, 2016)
  • D-1471-2016 Class III — Acetasol HC (hydrocortisone and acetic acid otic solution USP) , Rx Only, 10 mL (August 2, 2016)
  • D-1448-2016 Class II — Dextroamphetamine Sulfate Extended-Release Capsules, 10 mg, 90- count bottles, R (July 11, 2016)
  • D-1457-2016 Class II — Glipizide 2.5 mg Extended-release tablets, 30-count bottle, Rx Only, Manufacture (June 30, 2016)
  • D-1148-2015 Class III — Lutera (0.1 mg levonorgestrel and 0.02 mg ethinyl estradiol tablets USP), 28 day (June 4, 2015)
  • D-0396-2015 Class II — Vancomycin Hydrochloride Capsules, USP, 125 mg, 2 x 10 count blister pack, Rx On (February 12, 2015)
  • D-0406-2015 Class II — Vancomycin Hydrochloride Capsules, USP, 250 mg, 2 x 10 count blister pack, Rx On (February 12, 2015)